NLRP3 and Hepatic fibrosis: Gentiopicroside has been reported to inhibit the TLR4 and NLRP3 signaling pathways in macrophages, which brought the release of inflammatory factors, improvement of hepatocyte pyroptosis, and alleviation of the hepatic fibrosis (Yong et al., 2024).